ScreenerHero
SENZASenzaGen AB
STO · SE · Healthcare · Diagnostics & Research · senzagen.com
5.100SEK-1.54%Mkt Cap: 16.11M $P/E: —

SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMerieux S.A.
$9.51BUSDP/E 19.0
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap16.11M $
Enterprise Value14.32M $
Revenue (TTM)5.84M $
Gross Profit3.59M $
Net Income (TTM)-1.11M $
Revenue/Share0.1883 USD
Last Price5.100 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees36
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-52.40
PEG—
EV/EBITDA-37.17
EV/Revenue2.45
P/S2.79
P/B1.90
EPS (TTM)-0.36
EPS (Forward)-0.10
52W Range
4.60022% of range6.840
52W High6.840 SEK
52W Low4.600 SEK
Profitability
Gross Margin64.80%
Oper. Margin-13.84%
EBITDA Margin-6.60%
Profit Margin-19.99%
ROE-14.91%
ROA-9.98%
Growth
Revenue Growth13.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-652.63K $
CapEx (TTM)524.84K $
FCF Margin-19.40%
FCF Yield-7.03%
Net Debt-1.79M $
Net Debt/EBITDA4.64
Balance Sheet
Debt/Equity0.24
Current Ratio2.90
Quick Ratio2.64
Book Value/Sh2.765 SEK
Cash/Share1.093 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.32.51M
Float24.40M
Insiders24.90%
Institutions12.11%
Technical
SMA 505.443 (-6.3%)
SMA 2005.598 (-8.9%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)8.73K
Avg Vol (10d)10.36K
Technical Indicators
RSI (14)42.5
MACD-0.0584
MACD Signal-0.0633
MACD Hist.+0.0049
BB Upper5.393 SEK
BB Middle5.270 SEK
BB Lower5.147 SEK
BB Width4.69%
ATR (14)0.2169 SEK
Vol Ratio (20d)3.76x